March 24, 2017 11:59 PM ET

Biotechnology

Company Overview of NexGenix Pharmaceuticals Holdings, Inc.

Key Executives for NexGenix Pharmaceuticals Holdings, Inc.

NameBoard RelationshipsTitleAge
Allan E. Rubenstein M.D.16 RelationshipsChief Executive Officer, President and Director71
Ruihong Chen Ph.D.No RelationshipsDirector of Preclinical Research & Development--

NexGenix Pharmaceuticals Holdings, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Allan E. Rubenstein M.D. 16 RelationshipsNexGenix Pharmaceuticals Holdings, Inc.71
Allen B. Salmasi Ph.D. 10 RelationshipsNLabs Inc.62
Neal Rosen Ph.D., M.D. 102 RelationshipsBeiGene, Ltd.--
Hen Suh Park Ph.D. 6 RelationshipsNexGenix Pharmaceuticals Holdings, Inc.--
Mauro Geller M.D., Ph.D. 6 RelationshipsNexGenix Pharmaceuticals Holdings, Inc.--
View All Board Members

NexGenix Pharmaceuticals Holdings, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
319.0K
Bonus
234.2K
Total Short Term Compensation
400.3K
Total Value of Options
2.9M
Compensation as of Fiscal Year
NexGenix Pharmaceuticals Holdings, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Retrophin, Inc. Appoints John A. Orwin to Board of Directors
March 23, 2017 9:11 PM ET
Arbutus Biopharma Corporation Appoints Daniel Burgess to the Board of Directors and Audit Committee
March 23, 2017 8:30 PM ET
Ascendis Pharma A/S Announces Resignation of Rafaèle Tordjman as Member of Board of Directors
March 23, 2017 8:21 PM ET
XBiotech, Inc. Announces Addition of Dr. Dirk Arnold to its Scientific Advisory Board
March 23, 2017 12:00 PM ET
Biovie Appoints Julie G. Anderson as an Independent Member of the Company's Board of Director
March 23, 2017 9:11 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NexGenix Pharmaceuticals Holdings, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.